The bad thing is that post Brexit, it seems that the MHRA has gotten a bit backlogged and isn’t able to keep up with our current demands on their time. It takes too long to get meetings and responses to applications currently. We’ve had to take our first human clinical trial to Australia, where it’s a faster, more streamlined, and cheaper process.
I think Insilico has opened an office in the middle east (don’t remember the country). I can see some countries deciding that testing drugs could be a growth industry for them.
1 Like
They’re in Abu Dhabi, UAE 
.
Australia did a good job at streamlining processes for trials.
But the real winner is China. That’s where the innovation happens now: x.com